- Trials with a EudraCT protocol (285)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (5)
285 result(s) found for: Surgeon.
Displaying page 1 of 15.
EudraCT Number: 2020-000509-96 | Sponsor Protocol Number: NL71166.041.19 | Start Date*: 2020-05-14 |
Sponsor Name:Princess Maxima Center for pediatric oncology | ||
Full Title: Near-infrared fluorescence imaging using indocyanine green as an adjunct to improve standard-of-care sentinel lymph node procedure in pediatric patients with melanoma or sarcoma of head/neck/trunk,... | ||
Medical condition: Sentinel node procedure for pediatric patients with melanoma or sarcoma | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2022-000093-25 | Sponsor Protocol Number: 01_20012022 | Start Date*: 2022-05-05 | |||||||||||
Sponsor Name:Aarhus University Hospital | |||||||||||||
Full Title: The effect of lateral pectoral nerve block in combination with interscalene nerve block on opioid consumption and pain on awake shoulder arthroscopy patients - A feasibility study | |||||||||||||
Medical condition: Peri- and postoperative pain after shoulder arthroscopy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001886-33 | Sponsor Protocol Number: MK-8616-076-00 | Start Date*: 2012-10-30 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: Randomized, Controlled, Parallel Group, Double Blind Trial to Compare the Use of Deep or Standard Neuromuscular Blockade in Combination With Low or Standard Insufflation Pressures Using a 2x2 Fact... | |||||||||||||
Medical condition: Patients undergoing elective in-patient laparoscopic cholecystectomy procedures under general anesthesia with neuromuscular relaxation and active reversal of neuromuscular blockade | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) FI (Completed) GB (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001155-22 | Sponsor Protocol Number: Lap2014NMB | Start Date*: 2014-05-22 | ||||||||||||||||
Sponsor Name:Mona Ring Gätke | ||||||||||||||||||
Full Title: Muscle relaxation during open upper abdominal surgery -can the surgical conditions be optimized? (The laparotomy study) | ||||||||||||||||||
Medical condition: The aim of the study is to investigate if intense NMB improves surgical conditions during operation in patients scheduled for elective open upper abdominal surgery. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-003119-77 | Sponsor Protocol Number: NL67828.058.18 | Start Date*: 2020-02-24 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Near-infrared fluorescence imaging with IndoCyanine Green for the intraoperative identification of Gastrointestinal stromal cell tumours: a pilot study | ||
Medical condition: GIST Gastrointestinal stromal cell tumour | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002961-21 | Sponsor Protocol Number: NS918 | Start Date*: 2018-11-09 |
Sponsor Name:UZ Leuven | ||
Full Title: The effect of deep neuromuscular block and reversal with sugammadex on surgical conditions and perioperative morbidity in shoulder surgery using a deltopectoral approach | ||
Medical condition: Subject undergoing elective or semi-elective surgery to the gleno-humeral joint or the proximal humerus using a deltoideo-pectoral approach. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005521-39 | Sponsor Protocol Number: 241502 | Start Date*: 2016-06-20 | |||||||||||
Sponsor Name:Baxalta Innovations GmbH | |||||||||||||
Full Title: A Phase 3, Multicenter, Single-arm, Open-label Study of the Efficacy and Safety of B-Domain Deleted Recombinant Porcine Factor VIII (BAX 802) in Subjects with Congenital Hemophilia A with Factor VI... | |||||||||||||
Medical condition: Congenital Haemophilia A with Factor VIII Inhibitors | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) ES (Prematurely Ended) NL (Prematurely Ended) PL (Prematurely Ended) DE (Prematurely Ended) NO (Prematurely Ended) BG (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005576-33 | Sponsor Protocol Number: LT2380-PII-09/12 | Start Date*: 2013-09-03 |
Sponsor Name:Laboratoires Théa | ||
Full Title: Efficacy and safety assessment of intracameral T2380 (Fixed combination of lidocaïne, phenylephrine and tropicamide) to obtain mydriasis in patients with small pupils for cataract surgery by phacoe... | ||
Medical condition: The primary aim of this study is to evaluate mydriasis obtained with T2380 (Fixed combination of lidocaïne, phenylephrine and tropicamide) in patients with small pupils | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-004138-12 | Sponsor Protocol Number: TAK-330-3001 | Start Date*: 2022-04-11 | |||||||||||
Sponsor Name:Takeda Development Center Americas, Inc. | |||||||||||||
Full Title: A Phase 3, Prospective, Randomized, Open-label, Adaptive Group Sequential, Multicenter Trial with Blinded Endpoint Assessment to Evaluate the Efficacy and Safety of PROTHROMPLEX TOTAL for the Rever... | |||||||||||||
Medical condition: Patients on treatment with Factor Xa Inhibitor needing for an urgent intervention associated with a high risk of bleeding. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) DE (Trial now transitioned) BE (Trial now transitioned) AT (Trial now transitioned) NL (Trial now transitioned) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001300-30 | Sponsor Protocol Number: 2017_CERVPLEX_1.1 | Start Date*: 2017-10-03 |
Sponsor Name:UK für Anästhesieologie, Gemeinn. Sbg. Landeskliniken BetriebsgesmbH | ||
Full Title: Comparison of deep, intermediate and superficial cervical plexus block for carotid endarterectomies concerning paresis of the phrenic nerve, lung function and tissue distribution: a prospective, ra... | ||
Medical condition: deep, intermediate or superficial cervical plexus block for carotid endarterectomy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000333-40 | Sponsor Protocol Number: 11-534 | Start Date*: 2012-07-30 |
Sponsor Name:University Medical Center Utrecht | ||
Full Title: Towards plannable breast surgery: diagnostic accuracy of microbubble enhanced Iodine-125 seed localization of the sentinel lymph node (MIB study) | ||
Medical condition: Patient with breast cancer with an indication for sentinel lymph node biopsy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2016-005186-31 | Sponsor Protocol Number: 01062017 | Start Date*: 2018-06-06 | ||||||||||||||||
Sponsor Name:Department of Plastic Surgery, Breast and Burns Treatment | ||||||||||||||||||
Full Title: Fat Grafting with Ex-Vivo Expanded Adipose-Derived Stem Cells for Breast Reconstruction Following Mastectomy | ||||||||||||||||||
Medical condition: This study will include patients with genetic predisposition to development of breast cancer, who are offered prophylactic bilateral skin-sparring mastectomy. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003512-37 | Sponsor Protocol Number: OC-AP-ICG-IV-2 | Start Date*: 2014-10-13 |
Sponsor Name:Jules Bordet Institute | ||
Full Title: Study of the (intravenously injected) ICG (Indocyanine Green) imaging of tumoral implants in patients with peritoneal carcinomatosis from colorectal origin. | ||
Medical condition: Imaging of tumours and their metastasis after intravenous injection of Indocyanine Green to patients with peritoneal carcinomatosis from colorectal cancer. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003401-26 | Sponsor Protocol Number: 400-12-006 | Start Date*: 2014-05-16 |
Sponsor Name:Ethicon Inc. | ||
Full Title: A Prospective, Randomized, Controlled, Study Evaluating EVICEL® Fibrin Sealant as an Adjunct to Hemostasis During Abdominal, Retroperitoneal, Pelvic or Thoracic (Non‐Cardiac) Surgery in Pediatric P... | ||
Medical condition: Abdominal, Retroperitoneal, Pelvic or Thoracic (Non‐Cardiac) Surgery | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-003954-15 | Sponsor Protocol Number: BIOS-14-002 | Start Date*: 2015-05-06 |
Sponsor Name:Ethicon, Inc. | ||
Full Title: A single blinded, randomized, controlled study to evaluate the safety and effectiveness of EVICEL® Fibrin sealant (Human) compared to a Hydrogel sealant as an adjunct to sutured dural repair | ||
Medical condition: Cerebrospinal fluid leakage in posterior fossa or supratentorial procedures (craniectomy or craniotomy) during neurosurgery | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005972-34 | Sponsor Protocol Number: HJ1 | Start Date*: 2006-03-22 |
Sponsor Name:Fredericia Hospital | ||
Full Title: Retrograd intrarenal stenkirurgi. En metode til behandling af den ESWL-resistente nyresten | ||
Medical condition: kidney stone | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001660-30 | Sponsor Protocol Number: CHL.3/01-2019/M | Start Date*: 2020-06-03 | |||||||||||
Sponsor Name:Sintetica S.A. | |||||||||||||
Full Title: A prospective, observer-masked, randomized clinical trial to investigate and compare the clinical efficacy of chloroprocaine 3% gel and tetracaine 0.5% eye drop as topical anesthetics in phacoemuls... | |||||||||||||
Medical condition: cataract surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003556-39 | Sponsor Protocol Number: DARINA | Start Date*: 2012-06-05 |
Sponsor Name:Martini Hospital Groningen | ||
Full Title: A randomized pilot study comparing the safety of DAbigatran and RIvaroxaban versus NAdroparin in the prevention of venous thromboembolism after knee arthroplasty surgery. DARINA | ||
Medical condition: After total knee arthroplasty (TKA) surgery, patients are at risk to develop venous thromboembolism (VTE). Two novel agents, dabigatran and rivaroxaban, recently gained market authorisation for pre... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-004835-39 | Sponsor Protocol Number: 400-08-002 | Start Date*: 2008-11-13 |
Sponsor Name:OMRIX biopharmaceuticals Ltd | ||
Full Title: A Phase III Randomized, Controlled, Superiority Study Evaluating the Fibrin Pad Versus Standard of Care Treatment in Controlling Severe Soft Tissue Bleeding During Abdominal, Retroperitoneal, Pelvi... | ||
Medical condition: Patients undergoing abdominal, pelvic, retroperitoneal, and (non-cardiac) thoracic surgery. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-018776-24 | Sponsor Protocol Number: HIPPoS | Start Date*: 2010-11-21 | |||||||||||
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust | |||||||||||||
Full Title: Proof of mechanism study of an oral hedgehog inhibitor (GDC-0449) in patients with resectable pancreatic ductal adenocarcinoma in the pre-operative window period. | |||||||||||||
Medical condition: Pancreatic ductal adenocarcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
